Genomic Health

NCI Study

Learn how the NCI is using Oncotype DX to assign treatment to more than 11,000 breast cancer patients in landmark personalized medicine trial.

Colon Test Available!

For additional information about the Oncotype DX® Colon Cancer test, please call: (866) 662-6897 or click here for details.

Video

A step-by-step "demo" of the Oncotype DX Breast Cancer Test.
See how Genomic Health is turning the promise of genomics into the practice of medicine

Click here to read Our Perspective on....

Why Healthcare Reform Must Not Overlook Medicare’s Current Barriers to Timely Lab Testing

Press Releases

March 8, 2010 Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
March 1, 2010 Genomic Health Develops New Methods for Whole Genome Expression Analysis of Standard Pathology Tumor Specimens

March 8, 2010

Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors

March 1, 2010

Genomic Health Develops New Methods for Whole Genome Expression Analysis of Standard Pathology Tumor Specimens